Literature DB >> 2159529

Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment.

M Mackett1, M J Conway, J R Arrand, R S Haddad, L M Hutt-Fletcher.   

Abstract

Computer-assisted analysis of the Epstein-Barr virus (EBV) open reading frame BILF2 (B95-8 nucleotides 150,525 to 149,782) predicts that it codes for a membrane-bound glycoprotein. [3H]glucosamine labeling of cells infected with vaccinia virus recombinants that expressed the BILF2 open reading frame revealed several diffuse species of glycoproteins of around 80,000 and 55,000 daltons. A monoclonal antibody derived from spleens of mice immunized with EBV immunoprecipitated the EBV-derived protein made by the vaccinia virus recombinants and also precipitated a late envelope glycoprotein with a mobility of 78,000 to 55,000 from EBV-producing cells. N-Glycanase treatment of the immunoprecipitated BILF2 product from EBV-producing cells resulted in a polypeptide of 28 kilodaltons, closely agreeing with the predicted molecular mass for the unmodified BILF2 gene product. Western (immuno-) blots using recombinant infected cells as a source of antigen showed that the majority of EBV-seropositive individuals have a serum antibody response to the BILF2-encoded gp78/55.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159529      PMCID: PMC249430          DOI: 10.1128/JVI.64.6.2545-2552.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

3.  New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.

Authors:  L Heston; M Rabson; N Brown; G Miller
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

4.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

5.  Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments.

Authors:  J R Arrand; L Rymo; J E Walsh; E Björck; T Lindahl; B E Griffin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

6.  Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.

Authors:  D A Thorley-Lawson; K Geilinger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen.

Authors:  G J Hoffman; S G Lazarowitz; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.

Authors:  J P Weir; G Bajszár; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement.

Authors:  G R Nemerow; N R Cooper
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  14 in total

Review 1.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

Review 2.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.

Authors:  C M Borza; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

4.  Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Authors:  Nina Orlova; Mark H Fogg; Angela Carville; Fred Wang
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

5.  Gibbs motif sampling: detection of bacterial outer membrane protein repeats.

Authors:  A F Neuwald; J S Liu; C E Lawrence
Journal:  Protein Sci       Date:  1995-08       Impact factor: 6.725

6.  Role of the TSG101 gene in Epstein-Barr virus late gene transcription.

Authors:  Huey-Huey Chua; Heng-Huan Lee; Shih-Shin Chang; Chih-Chung Lu; Te-Huei Yeh; Tsuey-Ying Hsu; Tzu-Hao Cheng; Jiin-Tsuey Cheng; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress.

Authors:  Antonella Farina; Regina Feederle; Salvatore Raffa; Roberta Gonnella; Roberta Santarelli; Luigi Frati; Antonio Angeloni; Maria Rosaria Torrisi; Alberto Faggioni; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein.

Authors:  J P Stewart; N J Janjua; S D Pepper; G Bennion; M Mackett; T Allen; A A Nash; J R Arrand
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors.

Authors:  P R Smith; Y Gao; L Karran; M D Jones; D Snudden; B E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.